NY A04798 proposes to prohibit the administration of COVID-19 mRNA vaccines in New York State and requires the Department of Health to conduct a comprehensive self-controlled case series study within one year to evaluate the benefits and risks of these vaccines before they can resume administration. The bill would immediately halt mRNA COVID-19 vaccinations upon passage and allow them to resume only after the department completes its analysis and determines the vaccines are safe. The legislation essentially creates a temporary moratorium on mRNA COVID-19 vaccine administration pending state-level investigation of vaccine safety and efficacy data.

Why It Matters to MAHA

This bill directly advances MAHA's core principle of health freedom and patient autonomy by requiring transparent, independent evaluation of medical interventions before they are administered. Rather than accepting federal authorization at face value, NY A04798 demands that New York conduct its own rigorous safety analysis, reflecting MAHA's commitment to transparency in healthcare and skepticism toward regulatory bodies that may prioritize corporate interests over public health. The bill empowers the state to make evidence-based decisions about vaccine policy rather than deferring to federal agencies, aligning with MAHA's emphasis on decentralized health decision-making and informed consent. By mandating a self-controlled case series study comparing each individual's health before and after vaccination, the bill seeks data that addresses legitimate questions about vaccine safety that many citizens have raised. MAHA supports legislative efforts that require thorough, independent scrutiny of medical treatments and restore public confidence through transparency rather than mandates.